XENETIC BIOSCIENCES, INC. Due to Related Parties, Current
XENETIC BIOSCIENCES, INC. (XBIO) had Due to Related Parties, Current of $0 as of 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2017-03-31
- 2016-12-31: Due to Related Parties, Current $0.00.
- 2016-09-30: Due to Related Parties, Current $152.53K.
- 2016-06-30: Due to Related Parties, Current $152.53K.
- 2016-03-31: Due to Related Parties, Current $157.95K.
| Period end | Due to Related Parties, Current |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-31 |
| 2016-09-30 | $152.53K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $152.53K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $157.95K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $395.00K 10-K · filed 2017-03-31 |
| 2015-09-30 | $395.00K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $395.00K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $395.00K 10-Q · filed 2015-05-20 |
| 2014-12-31 | $395.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $395.00K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $626.04K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $681.04K 10-Q · filed 2014-05-20 |
| 2013-12-31 | $681.12K 10-K · filed 2015-07-20 |
| 2012-12-31 | $682.99K 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |